RECURSION PHARMACEUTICALS, INC. Tax Credit Carryforward, Valuation Allowance
RECURSION PHARMACEUTICALS, INC. (RXRX) had Tax Credit Carryforward, Valuation Allowance of $11.80 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes
us-gaap:TaxCreditCarryforwardValuationAllowance · last filed 2026-02-25
- 2025-12-31: Tax Credit Carryforward, Valuation Allowance $11.80M.
- 2024-12-31: Tax Credit Carryforward, Valuation Allowance $6.70M.
- 2022-12-31: Tax Credit Carryforward, Valuation Allowance $2.80M.
- 2021-12-31: Tax Credit Carryforward, Valuation Allowance $1.90M.
| Period end | Tax Credit Carryforward, Valuation Allowance |
|---|---|
| 2025-12-31 | $11.80M 10-K · filed 2026-02-25 |
| 2024-12-31 | $6.70M 10-K · filed 2026-02-25 |
| 2022-12-31 | $2.80M 10-K · filed 2023-02-27 |
| 2021-12-31 | $1.90M 10-K · filed 2023-02-27 |
| 2020-12-31 | $1.10M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |